These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6312481)

  • 41. Chronic administration of delta-9-tetrahydrocannabinol to pregnant rats: studies of pup behavior and placental transfer.
    Vardaris RM; Weisz DJ; Fazel A; Rawitch AB
    Pharmacol Biochem Behav; 1976 Mar; 4(3):249-54. PubMed ID: 945578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat.
    Nakamura EM; da Silva EA; Concilio GV; Wilkinson DA; Masur J
    Drug Alcohol Depend; 1991 Aug; 28(2):167-75. PubMed ID: 1657563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat.
    Coupar IM; Taylor DA
    Br J Pharmacol; 1982 May; 76(1):115-9. PubMed ID: 6282371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time course and dose-response effects of orally administered delta-9-THC on interval schedule performance of the rat.
    Elsmore TF; Manning FJ
    Life Sci; 1974 Aug; 15(3):481-9. PubMed ID: 4549930
    [No Abstract]   [Full Text] [Related]  

  • 45. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biphasic effects of 9 -tetrahydrocannabinol on variable interval schedule performance in rats.
    Grisham MG; Ferraro DP
    Psychopharmacologia; 1972; 27(2):163-9. PubMed ID: 4638211
    [No Abstract]   [Full Text] [Related]  

  • 47. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
    Wiebelhaus JM; Grim TW; Owens RA; Lazenka MF; Sim-Selley LJ; Abdullah RA; Niphakis MJ; Vann RE; Cravatt BF; Wiley JL; Negus SS; Lichtman AH
    J Pharmacol Exp Ther; 2015 Feb; 352(2):195-207. PubMed ID: 25398241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors influencing tolerance to the effects of delta9-THC on a conditioned avoidance response.
    Larsen FF; Pryor GT
    Pharmacol Biochem Behav; 1977 Oct; 7(4):323-9. PubMed ID: 928490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats.
    Barrett RL; Wiley JL; Balster RL; Martin BR
    Psychopharmacology (Berl); 1995 Apr; 118(4):419-24. PubMed ID: 7568628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Labor division of rats under the influence of prolonged administration of (-) 9 -trans-tetrahydrocannabinol.
    Masur J
    Pharmacology; 1973; 9(1):35-40. PubMed ID: 4708976
    [No Abstract]   [Full Text] [Related]  

  • 51. Aspects of tolerance to and dependence on cannabis.
    Wikler A
    Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of reinforcement loss in tolerance to chronic delta9-tetrahydrocannabinol effects on operant behavior of rhesus monkeys.
    Elsmore TF
    Pharmacol Biochem Behav; 1976 Aug; 5(2):123-8. PubMed ID: 825882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attenuation of delta 9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1981; 73(1):97-8. PubMed ID: 6262850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in rats.
    Semjonow A; Binder M
    Psychopharmacology (Berl); 1985; 85(2):178-83. PubMed ID: 2989965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vehicle and route of administration as parameters affecting operant behavioral effects of 9 -tetrahydrocannabinol.
    Borgen LA; Davis WM
    J Pharm Sci; 1973 Mar; 62(3):479-80. PubMed ID: 4691712
    [No Abstract]   [Full Text] [Related]  

  • 56. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic delta 9-tetrahydrocannabinol administration and schedule-induced aggression.
    Cherek DR; Thompson T; Kelly T
    Pharmacol Biochem Behav; 1980 Feb; 12(2):305-9. PubMed ID: 6246545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of acute and chronic administration of delta 9-tetrahy-drocannabinol or cocaine on ethanol intake in a rat model.
    McMillan DE; Snodgrass SH
    Drug Alcohol Depend; 1991 May; 27(3):263-74. PubMed ID: 1653131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of tolerance to 9 -tetrahydrocannabinol in chimpanzees.
    Ferraro DP; Grilly DM
    Science; 1973 Feb; 179(4072):490-2. PubMed ID: 4705343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats.
    Panlilio LV; Solinas M; Matthews SA; Goldberg SR
    Neuropsychopharmacology; 2007 Mar; 32(3):646-57. PubMed ID: 16738542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.